Indeed, silencing of Plk1 levels by RNAi or inhibition of Plk1 activity by specific inhibitor is capable of decreasing the growth of most cancer cells, influencing mitotic spindle formation, and promoting apoptosis9–12. The gene discussed is PLK1; the disease is cancer.